Australian Clinical Labs Limited (ASX:ACL)
Australia flag Australia · Delayed Price · Currency is AUD
2.620
+0.020 (0.77%)
Sep 8, 2025, 4:10 PM AEST

Australian Clinical Labs Company Description

Australian Clinical Labs Limited provides pathology diagnostic services in Australia.

The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veterinary and functional pathology services; pathology services for clinical trials; and CPD programs.

It serves doctors, patients, and corporate clients. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

Australian Clinical Labs Limited
CountryAustralia
Founded2020
IndustryDiagnostics & Research
SectorHealthcare
Employees4,700
CEOMelinda McGrath

Contact Details

Address:
1868-1892 Dandenong Road
Clayton, 3168
Australia
Phone61 1 3004 53688
Websiteclinicallabs.com.au

Stock Details

Ticker SymbolACL
ExchangeAustralian Securities Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU0000148496
SIC Code8071

Key Executives

NamePosition
Rob IzzardChief Executive Officer of ACL Commercial Pathology
Shae SeymourChief Executive Officer of WA/SA/NT
Chris BrownlowChief Executive Officer of New South Wales and Australian Capital Territory
Melinda McGrathChief Executive Officer and Executive Director
Matthew CordingleyChief Financial Officer
Anthony FriedliChief Operating Officer
Sean JacksonChief Information Officer
Joe GeranNational Marketing Director
Associate Prof. Tony LandgrenNational Medical Director and Chief Pathologist
Eleanor Padman B.A., FCISCompany Secretary